CRN Denounces FDA Rejection of New Dietary Ingredient Notifications for Hemp Extract Containing CBD, Urges Congress to Act
Cannabis Law Report
AUGUST 11, 2021
The following is a statement from CRN President & CEO Steve Mister: “CRN is extremely disappointed to learn that FDA rejected NDI notifications for full-spectrum hemp extract containing CBD submitted earlier this year by supplement manufacturers Charlotte’s Web and Irwin Naturals. In December 2019, CRN and FDA met to discuss these issues.
Let's personalize your content